Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation.

作者: Jessica E. Hutti , Adam D. Pfefferle , Sean C. Russell , Mayukh Sircar , Charles M. Perou

DOI: 10.1158/0008-5472.CAN-11-4141

关键词:

摘要: The PI3K pathway is one of the most commonly misregulated signaling pathways in human cancers, but its impact on tumor microenvironment has not been considered as deeply autonomous cells. In this study we demonstrate that NF-κB activated by two common mutations, PIK3CA E545K and H1047R. We found markers are strongly upregulated under conditions growth factor deprivation. Gene expression analysis performed cells deprived factors identified repertoire genes altered oncogenic mutations following This gene set closely correlated with signatures from claudin-low basal-like breast tumors, subtypes frequently exhibiting constitutive PI3K/Akt activity. An NF-κB-dependent subset driven was also encoded primarily secreted proteins, suggesting a paracrine role for set. Interestingly, while oncogenes such Ras EGFR leads to cell-autonomous effects, abrogating PI3K-transformed did decrease proliferation or induce apoptosis. However, conditioned media mutant-expressing led increased STAT3 activation recipient THP-1 monocytes normal epithelial IL-6-dependent manner. Together, our findings describe PI3K-driven, transcriptional profile which may play critical promoting amenable progression. These data indicate plays diverse roles downstream different pathways.

参考文章(50)
Yinon Ben-Neriah, Michael Karin, Inflammation meets cancer, with NF-κB as the matchmaker Nature Immunology. ,vol. 12, pp. 715- 723 ,(2011) , 10.1038/NI.2060
Sandra R. Wolman, Herbert D. Soule, Charles M. McGrath, Richard F. Jones, Ward D. Peterson, Jose Russo, S. C. Brooks, Robert J. Pauley, Terry M. Maloney, Richard Brenz, Isolation and Characterization of a Spontaneously Immortalized Human Breast Epithelial Cell Line, MCF-10 Cancer Research. ,vol. 50, pp. 6075- 6086 ,(1990)
Karl Ziegelbauer, Florian Gantner, Nicholas W Lukacs, Aaron Berlin, Kinji Fuchikami, Toshiro Niki, Katsuya Sakai, Hisayo Inbe, Keisuke Takeshita, Mina Ishimori, Hiroshi Komura, Toshiki Murata, Timothy Lowinger, Kevin B Bacon, A selective novel low-molecular-weight inhibitor of IκB kinase-β (IKK-β) prevents pulmonary inflammation and shows broad anti-inflammatory activity British Journal of Pharmacology. ,vol. 145, pp. 178- 192 ,(2005) , 10.1038/SJ.BJP.0706176
Daniela S Bassères, Aaron Ebbs, Elena Levantini, Albert S Baldwin, None, Requirement of the NF-κB Subunit p65/RelA for K-Ras–Induced Lung Tumorigenesis Cancer Research. ,vol. 70, pp. 3537- 3546 ,(2010) , 10.1158/0008-5472.CAN-09-4290
H J Kim, N Hawke, A S Baldwin, NF-κB and IKK as therapeutic targets in cancer Cell Death & Differentiation. ,vol. 13, pp. 738- 747 ,(2006) , 10.1038/SJ.CDD.4401877
Michael Karin, Florian R. Greten, NF-kappaB: linking inflammation and immunity to cancer development and progression. Nature Reviews Immunology. ,vol. 5, pp. 749- 759 ,(2005) , 10.1038/NRI1703
Andrew Green, Mohammed Aleskandarany, Emad Rakha, Mohamed Ahmed, Desmond Powe, Emma Paish, R Macmillan, Ian Ellis, None, PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis Breast Cancer Research and Treatment. ,vol. 122, pp. 45- 53 ,(2010) , 10.1007/S10549-009-0508-9